Announcements
24 February 2025
Journal of Clinical Medicine | Highly Cited Papers and Hot Topic Special Issues on Epilepsy
Epilepsy is a chronic brain disorder that cannot be ignored and affects many patients. Its causative factors are complex, and clinicians and scientists are constantly updating their research on the condition. Journal of Clinical Medicine (JCM, ISSN: 2077-0383) has collected open academic research on epilepsy. Some relevant Special Issues are currently open for the submissions; we encourage you to read these highly popular works in depth. Please click the links below to learn more about these papers:
1. “Epilepsy in Dravet Syndrome—Current and Future Therapeutic Opportunities”
by Chao Gao, Mikolaj Pielas, Fuyong Jiao, Daoqi Mei, Xiaona Wang, Katarzyna Kotulska and Sergiusz Jozwiak
J. Clin. Med. 2023, 12(7), 2532; https://doi.org/10.3390/jcm12072532
Full text available online: https://www.mdpi.com/2077-0383/12/7/2532
2. “Glycaemic Imbalances in Seizures and Epilepsy of Paediatric Age: A Literature Review”
by Emanuele Bartolini, Anna Rita Ferrari, Simona Fiori and Stefania Della Vecchia
J. Clin. Med. 2023, 12(7), 2580; https://doi.org/10.3390/jcm12072580
Full text available online: https://www.mdpi.com/2077-0383/12/7/2580
3. “Characteristics and Challenges of Epilepsy in Children with Cerebral Palsy—A Population-Based Study”
by Ana Dos Santos Rufino, Magnus Påhlman, Ingrid Olsson and Kate Himmelmann
J. Clin. Med. 2023, 12(1), 346; https://doi.org/10.3390/jcm12010346
Full text available online: https://www.mdpi.com/2077-0383/12/1/346
4. “Therapeutic Strategies in Children with Epilepsy: A Quality-of-Life-Related Perspective”
by Hideaki Kanemura
J. Clin. Med. 2024, 13(2), 405; https://doi.org/10.3390/jcm13020405
Full text available online: https://www.mdpi.com/2077-0383/13/2/405
5. “Cenobamate Plasma Levels in Patients with Epilepsy: Correlation with Efficacy and Tolerability?”
by Bernhard J. Steinhoff, Dimitra Georgiou, Daniel Dietmann and Tassanai Intravooth
J. Clin. Med. 2024, 13(10), 2757; https://doi.org/10.3390/jcm13102757
Full text available online: https://www.mdpi.com/2077-0383/13/10/2757
6. “Cognitive Impairment in People with Epilepsy”
by Ajda Novak, Karmen Vizjak and Martin Rakusa
J. Clin. Med. 2022, 11(1), 267; https://doi.org/10.3390/jcm11010267
Full text available online: https://www.mdpi.com/2077-0383/11/1/267
7. “Detecting Reasons for Nonadherence to Medication in Adults with Epilepsy: A Review of Self-Report Measures and Key Predictors”
by Sarah Mendorf, Tino Prell and Aline Schönenberg
J. Clin. Med. 2022, 11(15), 4308; https://doi.org/10.3390/jcm11154308
Full text available online: https://www.mdpi.com/2077-0383/11/15/4308
8. “Vagus Nerve Stimulation for Drug Resistant Epilepsy: Clinical Outcome, Adverse Events, and Potential Prognostic Factors in a Single Center Experience”
by Ming Shan, Hongliang Mao, Hutao Xie, Yifei Gan, Delong Wu, Jian Song, Yutong Bai and Jianguo Zhang
J. Clin. Med. 2022, 11(24), 7536; https://doi.org/10.3390/jcm11247536
Full text available online: https://www.mdpi.com/2077-0383/11/24/7536
9. “Early Epilepsy Surgery in Benign Cerebral Tumors: Avoid Your ‘Low-Grade’ Becoming a ‘Long-Term’ Epilepsy-Associated Tumor”
by Catrin Mann, Nadine Conradi, Elisabeth Neuhaus, Jürgen Konczalla, Thomas M. Freiman, Andrea Spyrantis, Katharina Weber, Patrick Harter, Felix Rosenow, Adam Strzelczyk et al.
J. Clin. Med. 2022, 11(19), 5892; https://doi.org/10.3390/jcm11195892
Full text available online: https://www.mdpi.com/2077-0383/11/19/5892
10. “A Multi-Disciplinary Team Approach to Genomic Testing for Drug-Resistant Epilepsy Patients—The GENIE Study”
by Lata Vadlamudi, Carmen Maree Bennett, Melanie Tom, Ghusoon Abdulrasool, Kristian Brion, Ben Lundie, Hnin Aung, Chiyan Lau, Jonathan Rodgers, Kate Riney et al.
J. Clin. Med. 2022, 11(14), 4238; https://doi.org/10.3390/jcm11144238
Full text available online: https://www.mdpi.com/2077-0383/11/14/4238
| Special Issues: | |
|
“Clinical Therapeutic and Management Strategies of Epilepsy—Social and Neuropsychological |
“Neurosurgery: Current Challenges and New Perspectives” |
 |
 |
18 February 2025
Journal of Clinical Medicine | Issue Cover Articles in 2024 (II)
Journal of Clinical Medicine (JCM, ISSN: 2077-0383) is a semimonthly journal, published online by MDPI. The Editorial Office has selected 24 articles as issue cover articles in 2024. We welcome you to read the second part of these articles to learn about the current trends, challenges, and innovative solutions in clinical medicine. To access the full Volume 13, please visit https://www.mdpi.com/2077-0383/13.
|
|
1. “Diagnosis of Pulmonary Embolism: A Review of Evidence-Based Approaches” |
|
|
2. “A Review of Myositis-Associated Interstitial Lung Disease” |
|
|
3. “Visual Outcomes of Cataract Surgery in Patients with Previous History of Implantable Collamer Lens” |
|
|
4. “Could Vaccination against COVID-19 Trigger Immune-Mediated Inflammatory Diseases?” |
|
|
5. “Transthoracic Cross Clamp versus Endoaortic Balloon Occlusion in Minimally Invasive Mitral Valve Surgery: A Pooled Study with Subgroup Analyses” |
|
|
6. “Hospitalization and Health Resource Utilization in Emergency Department Cases of Diabetic Foot Infections in the U.S. from 2012 to 2021: A Nationally Representative Analysis” |
|
|
7. “Chiropractic and Spinal Manipulation: A Review of Research Trends, Evidence Gaps, and Guideline Recommendations” |
|
|
8. “Association of Hypertension with Different Cognitive Disorders” |
|
|
9. “Chest Tubes and Pleural Drainage: History and Current Status in Pleural Disease Management” |
|
|
10. “Challenges and Considerations in Diagnosing and Managing p16+-Related Oropharyngeal Squamous Cell Carcinoma (OPSCC) with Neck Metastasis: Implications of p16 Positivity, Tobacco Exposure, and De-Escalation Strategies” |
|
|
11. “Comparative Analysis of Real-World Clinical Outcomes of a Novel Pulsed Field Ablation System for Pulmonary Vein Isolation: The Prospective CIRCLE-PVI Study” |
|
|
12. “Screening for Alcohol Use Disorder Among Hospitalised Patients: Learning from a Retrospective Cohort Study in Secondary Care” |
17 February 2025
MDPI Celebrates Excellence in Medical Research with Early Career Researcher Awards
MDPI, a pioneer in scholarly open access publishing, and the Lee Kong Chian School of Medicine (LKCMedicine), Singapore, proudly announce the successful conclusion of the first edition the MDPI Early Career Researcher Awards. The awards, which recognize outstanding contributions to medical and biomedical research, were presented to six exceptional researchers during an awards ceremony held at LKCMedicine HQ Building on 28 November 2024.
|
|
|
Honoring Excellence in Research
The awards recognize exceptional postdoctoral researchers and Ph.D. students who have demonstrated outstanding originality, innovation, and impact in their respective fields. We are honored to announce the winners of the 2024 edition:
Early Career Researcher (Postdoc) Award:
- Dr. Theresia Handayani Mina, “Adiposity and Metabolic Health in Asian Populations: An Epidemiological Study Using Dual-Energy X-Ray Absorptiometry in Singapore”;
- Dr. Erfan Rezvani Ghomi, “Wound Healing Improvement by Novel Aligned Antimicrobial Nanofibrous 3D Scaffolds”;
- Dr. Yadollah Ranjbar Slamloo, “Functional Alterations of The Prefrontal Circuit Underlying Cognitive Aging in Mice”.
Early Career Researcher (Ph.D.) Award:
- Pritisha Rozario, “Mechanistic Basis for Potassium Efflux-Driven Activation of the Human NLRP1 Inflammasome”;
- Michelle Law Cheok Yien, “Chikungunya Virus Nonstructural Protein 1 is a Versatile RNA Capping and Decapping Enzyme”;
- Yin Ruoyu, “The Use of Digital Mental Health and Wellbeing Tools in Older Adults: A Mixed Method Study”.
Our collaboration highlights a shared commitment to recognizing exceptional talent and research within the academic community, addressing today’s healthcare challenges, and inspiring continued innovation.
|
|
|
|
|
|
|
|
|
Looking Ahead to 2025
Building on the success of the first edition, MDPI and LKCMedicine are excited to announce that the 2025 MDPI Early Researcher Awards will continue to celebrate excellence and innovation in medical research. The next edition promises to expand its scope, introducing new categories and providing even greater recognition for impactful research.
Further details on the 2025 awards, including nomination criteria and timelines, will be shared in the coming months. We remain committed to fostering a culture of research excellence and collaboration within the global scientific community.
|
|
13 February 2025
Journal of Clinical Medicine | Title Story Articles for the Second Half of 2024
7 February 2025
Journal of Clinical Medicine | Highly Cited Papers in 2024 and Hot Topic Special Issues in the Section “Cardiovascular Medicine”
We are delighted to share some highly cited papers from the “Cardiovascular Medicine” Section that were published in the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) in 2024. You are welcome to read these highly cited papers and find the latest publications through this link: https://www.mdpi.com/search?journal=jcm§ion=1662. Additionally, some Special Issues in the “Cardiovascular Medicine” Section are currently open for submissions. The following is a list of articles and Special Issues that we believe may interest you:
1. “Systemic Immune-Inflammation Index and Systemic Inflammatory Response Index as Predictors of Mortality in ST-Elevation Myocardial Infarction”
by Federica Marchi, Nataliya Pylypiv, Alessandra Parlanti, Simona Storti, Melania Gaggini, Umberto Paradossi, Sergio Berti and Cristina Vassalle
J. Clin. Med. 2024, 13(5), 1256; https://doi.org/10.3390/jcm13051256
Full text available online: https://www.mdpi.com/2077-0383/13/5/1256
2. “The Effects of Obstructive Sleep Apnea on the Cardiovascular System: A Comprehensive Review”
by Michael V. DiCaro, KaChon Lei, Brianna Yee and Tahir Tak
J. Clin. Med. 2024, 13(11), 3223; https://doi.org/10.3390/jcm13113223
Full text available online: https://www.mdpi.com/2077-0383/13/11/3223
3. “Optical Coherence Tomography in Myocardial Infarction Management: Enhancing Precision in Percutaneous Coronary Intervention”
by Angela Buonpane, Giancarlo Trimarchi, Marco Ciardetti, Michele Alessandro Coceani, Giulia Alagna, Giovanni Benedetti, Sergio Berti, Giuseppe Andò, Francesco Burzotta and Alberto Ranieri De Caterina
J. Clin. Med. 2024, 13(19), 5791; https://doi.org/10.3390/jcm13195791
Full text available online: https://www.mdpi.com/2077-0383/13/19/5791
4. “Advanced Lung Cancer Inflammation Index as Predictor of All-Cause Mortality in ST-Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention”
by Giancarlo Trimarchi, Fausto Pizzino, Alessio Lilli, Alberto Ranieri De Caterina, Augusto Esposito, Stefano Dalmiani, Annamaria Mazzone, Gianluca Di Bella, Sergio Berti and Umberto Paradossi
J. Clin. Med. 2024, 13(20), 6059; https://doi.org/10.3390/jcm13206059
Full text available online: https://www.mdpi.com/2077-0383/13/20/6059
5. “Pregnancy Arrhythmias: Management in the Emergency Department and Critical Care”
by Elena Conti, Nunzio Dario Cascio, Patrizia Paluan, Giulia Racca, Yaroslava Longhitano, Gabriele Savioli, Manfredi Tesauro, Roberto Leo, Fabrizio Racca and Christian Zanza
J. Clin. Med. 2024, 13(4), 1095; https://doi.org/10.3390/jcm13041095
Full text available online: https://www.mdpi.com/2077-0383/13/4/1095
6. “Rosuvastatin-Based Lipid-Lowering Therapy for the Control of LDL Cholesterol in Patients at High Vascular Risk”
by Jose María Mostaza and Carlos Escobar
J. Clin. Med. 2024, 13(7), 1894; https://doi.org/10.3390/jcm13071894
Full text available online: https://www.mdpi.com/2077-0383/13/7/1894
7. “Obesity in Hypertensive Patients Is Characterized by a Dawn Phenomenon in Systolic Blood Pressure Values and Variability”
by Dawid Lipski, Dorota Marzyńska, Paulina Sytek, Patrycja Rzesoś, Agnieszka Rabiza, Sebastian Żurek, Artur Radziemski, Łukasz Stryczyński, Andrzej Tykarski and Paweł Uruski
J. Clin. Med. 2024, 13(2), 371; https://doi.org/10.3390/jcm13020371
Full text available online: https://www.mdpi.com/2077-0383/13/2/371
8. “Heart Rate Variability and Cognition: A Narrative Systematic Review of Longitudinal Studies”
by Paola Nicolini, Gabriella Malfatto and Tiziano Lucchi
J. Clin. Med. 2024, 13(1), 280; https://doi.org/10.3390/jcm13010280
Full text available online: https://www.mdpi.com/2077-0383/13/1/280
9. “Multiparametric Monitoring of Disease Progression in Contemporary Patients with Wild-Type Transthyretin Amyloid Cardiomyopathy Initiating Tafamidis Treatment”
by Svenja Ney, Roman Johannes Gertz, Lenhard Pennig, Richard J. Nies, Udo Holtick, Linus A. Völker, Gilbert Wunderlich, Katharina Seuthe, Christopher Hohmann, Clemens Metze et al.
J. Clin. Med. 2024, 13(1), 284; https://doi.org/10.3390/jcm13010284
Full text available online: https://www.mdpi.com/2077-0383/13/1/284
10. “Focal Pulsed Field Ablation for Atrial Arrhythmias: Efficacy and Safety under Deep Sedation”
by Sebastian Weyand, Viola Adam, Paloma Biehler, Patricia Hägele, Simon Hanger, David Heinzmann, Stephanie Löbig, Andrei Pinchuk, Christian Waechter and Peter Seizer
J. Clin. Med. 2024, 13(2), 576; https://doi.org/10.3390/jcm13020576
Full text available online: https://www.mdpi.com/2077-0383/13/2/576
| Special Issues: | |
| “Advances in the Diagnosis and Treatment of Pulmonary Hypertension” Guest Editors: Dr. Takayuki Fujiwara and Dr. Shun Minatsuki Submission deadline: 31 March 2025 |
“Cardiovascular Disease and Diabetes: Management of Risk Factors” Guest Editors: Dr. Alfredo Caturano and Dr. Teresa Salvatore Submission deadline: 20 April 2025 |
 |
 |
| “Advanced Techniques for the Treatment of Complex Coronary Artery Disease: 2nd Edition” Guest Editor: Dr. Simone Calcagno Submission deadline: 31 May 2025 |
“Current Trends and Innovations in Coronary Artery Disease and Myocardial Ischemia” Guest Editor: Dr. Edoardo Conte Submission deadline: 30 June 2025 |
 |
 |
5 February 2025
MDPI INSIGHTS: The CEO's Letter #20 - Beijing, Singapore, Bangkok, JAMS, Jisc
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
2024 Annual Meeting – Beijing (15 January 2025)
You haven’t truly experienced a New Year’s celebration until you’ve attended one of MDPI’s Chinese Annual Meeting festivities. This year I visited our annual meeting in Beijing, held on the 15th of January.
Imagine this: stepping into a banquet hall filled with 140 tables and about 1,400 colleagues from our Beijing offices, all gathered to share in a six-hour event. The agenda included year-end speeches and presentations, a variety of performances by our colleagues, a selection of awards honouring local employees for their work, group photos for the memories, and a dinner.
This may have been one of the largest events I have attended. For those unaccustomed to such an event, it might seem overwhelming, but it was quite the opposite. The atmosphere was one of celebration as everyone came together to support their peers and celebrate the achievements of 2024.
I was honoured to deliver the opening speech and a presentation highlighting our growth and investment in MDPI’s most valuable asset: our people.
“Our editorial teams represent MDPI at its finest”
I want to give special recognition to the editorial department, across all of our offices, which forms the heart of our business. These teams are the frontline communicators with our authors, reviewers, and guest editors, creating a smooth experience of processing our manuscripts. Their professionalism and kindness are often highlighted as key drivers of satisfaction with MDPI. For this, I extend my deepest gratitude to all our editorial staff, across every office. They truly represent MDPI at its finest.
Beijing is home to two of our offices, with just over 800 employees in Tongzhou and over 600 in Haidian. Thank you to our administrative teams and everyone involved in organizing these New Year’s celebrations across all offices. These events provide a moment to reflect on our shared accomplishments and appreciate the positive impact each of you has on our culture.
MDPI Offices in China
While the history of MDPI begins in Basel, Switzerland, the story of MDPI is very much rooted in China. Below is a list of MDPI’s current offices in China and their respective dates of inauguration:
- 2008: Beijing (Tongzhou, Haidian)
- 2013: Wuhan (Hankou, Guanggu)
- 2019: Tianjin
- 2021: Dalian
- 2021: Nanjing
To date, over 381,000 MDPI research articles have been published by authors affiliated with Chinese institutions, making China our largest market. This is reflected not only in the volume of publications but also in the scale of our workforce supporting local operations and contributing to global success.
While no new offices in China were launched between 2022 and 2024 due to the pandemic and strategic planning, we remain committed to future growth here. Our plans include expanding operations as we continue to build our global workforce.
We look forward to a year filled with continued collaboration, growth, and shared success.
“We remain committed to future growth in China”
Impactful Research
MDPI and Jisc Consortium Extend Open Access Agreement for 2025
I’m pleased to share that MDPI has extended its agreement with the Jisc consortium in the UK for 2025. This renewal strengthens our partnership with UK institutions and reaffirms our shared commitment to advancing open access publishing.
Jisc is the UK’s not-for-profit digital, data, and technology agency supporting tertiary education, research, and innovation. Through initiatives such as our agreement, Jisc helps institutions access essential digital resources and infrastructure to support researchers. Currently, 62 UK institutions are part of our Institutional Open Access Program (IOAP) through this partnership.
Authors from participating institutions benefit from discounts on article processing charges (APCs), with even greater support for institutions that centrally fund APCs. This helps researchers focus on their work while simplifying the publishing process.
A full list of participating institutions can be found here.
As Becky Castellon, our Institutional Partnerships Manager, puts it: “Extending our agreement with Jisc is a reward for the strong partnership we’ve built with research institutions throughout the UK.”
At MDPI, we are dedicated to making research more accessible while reducing administrative burdens for institutions and authors. Open access publishing is at the heart of what we do, and we’re proud to expand its reach in the UK and beyond.
Inside MDPI
Visit to MDPI's Singapore office
During my January trip to some of our APAC offices, I also had the pleasure of visiting our Singapore office for the first time. It’s exciting to see how much the team has grown, now numbering over 55 staff members, with more joining us in February.
Welcoming and Supporting New Team Members
“Experienced staff play an important role in mentoring new hires”
I had the opportunity to connect with both experienced colleagues and new team members who are currently embarking on their careers. This visit reminded me of what it was like when I was in their shoes. I encourage all of us to engage new colleagues with empathy, as we have all been in their position. By creating a welcoming and supportive environment, we can help them settle in and learn about the corporate world, MDPI and our mission.
Experienced staff play an important role in mentoring and guiding new hires, most of whom are transitioning from academia to their first job. I’m especially grateful to colleagues such as Colin Chen, Alicia Ren, Yu Nwe Soe, Colin Wee, Amy Cham and other senior members who have contributed to shaping the culture and work environment in Singapore.
Building MDPI’s Positive Reputation
During my visit, I spoke with the office staff about the importance of their roles in building a positive reputation that helps create trust in MDPI. I shared how every interaction and communication point contributes to the marketing of MDPI and our journals. I also highlighted the career development opportunities available as MDPI continues to grow.
Connecting with the Singapore Marketing Team
I also spent time connecting directly with the Singapore Marketing team, which has quickly grown to 15 young and ambitious members. They are eager to learn and are actively contributing to our journal and corporate marketing activities. I shared insights into our corporate marketing structure and strategy and look forward to supporting them as they grow.
During the visit, I was joined by my colleague Dr. Constanze Schelhorn, Head of Indexing, who provided training on indexing. This training was greatly appreciated by the local staff.
Meeting with Prof. Dr. Manoj Gupta
Lastly, we had the privilege of meeting Prof. Dr. Manoj Gupta, Editor-in-Chief (EiC) of Technologies since 2016 and Section EiC of Metals.
Prof. Gupta is an active decision-maker for the journal and a great brand ambassador for MDPI.
Prof. Gupta has helped sustainably scale Technologies, which now has a 4.2 Impact Factor and a 6.7 CiteScore, ranking Q1 in the JCR category of Engineering and Q1 in the CiteScore category of Computer Science.
During our meeting, we discussed strategies for Institutional Open Access Partnership agreements and ways to promote MDPI journals in Singapore.
PS. During the visit, we also had the chance to participate in Lo Hei, also known as Yee Sang or the “prosperity toss.” This is a raw fish salad traditionally enjoyed during Chinese New Year and is particularly popular among Chinese communities in Singapore, Malaysia, and Indonesia. Everyone gathers around the table as the ingredients are added one by one, and then the salad is mixed together. It was a fun experience to take part in this New Year tradition!
Coming Together for Science
JAMS – Journal & Article Management System
I am excited to announce the official relaunch of JAMS (Journal & Article Management System), one of MDPI’s key initiatives to support academic publishers worldwide.
With this relaunch, JAMS now offers new pricing models and flexible solutions for small-scale journals, commercial publishers, and university presses. We have also redesigned the JAMS website to enhance the user experience.
“JAMS is a testament to our commitment to simplifying the publishing process”
Explore the new website here: jams.pub
It’s also great to see the JAMS team expanding our presence at conferences and on social media to engage more effectively with the academic community.
Recently, Facundo Santomé (Senior Marketing Manager) and Alex Ramos (Senior Marketing Specialist) represented JAMS at the APE 2025 conference in Berlin, highlighting how our platform empowers small and independent publishers to streamline and scale their journal management.
JAMS was built to change that by adapting to the unique requirements of each publisher.
At MDPI, we continually invest in our growth – not only by expanding our operations and staff but also by developing innovative products that serve the academic and publishing community at large. JAMS, with its comprehensive suite of journal management tools, is a testament to our commitment to simplifying the publishing process for our partners.
Imagine a submission system that frees up your time for strategy, innovation, and impactful publishing.
Under the leadership of Silvano Bonfatti (Product Manager, MDPI), the JAMS team has conducted in-depth market research to understand the challenges publishers face: endless administrative tasks, inefficient workflows, and systems that don’t always meet their needs.
If you believe JAMS could benefit any of your network contacts, please share our website. Contact the JAMS team. They are always ready to assist with your publishing needs.
What Sets JAMS Apart?
- Scalability – Whether you're a niche journal or managing thousands of submissions, JAMS grows with you.
- End-to-End Workflow – From submission to peer review and final publication, everything is in one place.
- Automation That Works for You – Say goodbye to chasing reviewers and formatting issues, so that you can focus on quality instead.
- Built by Publishers, for Publishers – JAMS is backed by MDPI’s expertise; we know exactly what it takes to run a journal smoothly.
- Flexible & Fair Pricing – Supporting journals of all sizes, with special rates for non-profits and publishers in the Global South.
Partners Who Already Trust JAMS
If you believe JAMS could benefit any of your network contacts, please share our website. Contact the JAMS team. They are always ready to assist with your publishing needs.
Closing Thoughts
Visit to MDPI's Bangkok office
To conclude my APAC trip, I had the pleasure of visiting our Bangkok office from 22 to 24 January. The office has grown significantly, closing 2024 with a total of 445 colleagues across various departments, including Editorial, Production, Conference, Training, Journal Relationship Specialists (JRS), Managing Editors, and supporting teams in HR, Admin, IT, and Finance.
I would like to praise our Bangkok management team for their excellent work in supporting our growth and creating a positive work environment. Our colleagues here are humble, talented, hardworking, and appreciative of MDPI’s mission.
Thailand was among MDPI’s top 30 markets in 2024 for total publications. With our office in Bangkok, we have an opportunity to further promote open access while supporting local researchers and institutions. This includes open access discounts, author training sessions, conference sponsorships, and other initiatives. We currently have 25 Editorial Board Members (EBMs) from Thailand and will work on expanding this network.
Engaging with Group Leads
“Group leads play an important role in creating a safe, positive environment”
During my visit, I met with our group leads to highlight their crucial role in managing journal performance and mentoring new employees, especially given our increased hiring targets. Many new hires are early in their careers and require training, development, and support. Group leads play an important role in creating a safe, positive environment that fosters professional growth while maintaining MDPI’s reputation for service quality.
To wrap up the session, I added a personal touch by holding the door and giving everyone high-fives – a small gesture to show appreciation, boost morale, and strengthen team spirit. It’s important for our colleagues to feel seen, heard, and valued.
University Visit: King Mongkut’s University of Technology North Bangkok (KMUTNB)
We also visited King Mongkut’s University of Technology North Bangkok (KMUTNB) to explore collaboration opportunities.
Our discussions focused on: Institutional Open Access Partnership (IOAP), Author training sessions, Conference sponsorships, Student employment initiatives, and more.
This visit reinforced the importance of building strong relationships with local universities, ensuring we continue to support and engage with the academic community in Thailand.
“My time in Bangkok was productive and inspiring”
My time in Bangkok was productive and inspiring. The senior team has done a great job in growing the office and creating a supportive, high-performing environment. I look forward to seeing continued success from our colleagues in Thailand.
Chief Executive Officer
MDPI AG
4 February 2025
World Cancer Day 2025—United in Every Journey
Cancer impacts millions of lives worldwide, yet each person’s journey with the disease is uniquely their own. World Cancer Day reminds us that while the disease impacts individuals differently, our shared strength, innovation, and focus on holistic care bring us closer to a future where cancer no longer dictates lives. Every experience, challenge, and success story contribute to the broader fight against cancer, demonstrating the resilience and hope that unite us all. As we continue to make strides through innovative research, treatment advancements, and global collaboration, it is essential to recognize both the diversity of stories and our common goal of overcoming cancer together.
In observance of this day, we invite you to explore the following resources that delve into the field of cancer and the cutting-edge advancements shaping its care. By prioritizing people-centered treatment where patients’ voices and needs guide care, we can ensure personalized attention for all. It is our hope to foster a deeper understanding of the impact of cancer and encourage meaningful action to support patients, caregivers, and researchers in their pursuit of a world free from cancer’s hold. Together, we can inspire action and work toward a cancer-free future.
 |
|
Biology & Life Sciences |
Medicine & Pharmacology |
Chemistry & Material Sciences Public Health & Healthcare Engineering Society |
 |
“Rare Variants of Dermatofibrosarcoma Protuberans: Clinical, Histologic, and Molecular Features and Diagnostic Pitfalls”
by Celestine M. Trinidad, Sintawat Wangsiricharoen, Victor G. Prieto and Phyu P. Aung
Dermatopathology 2023, 10(1), 54–62; https://doi.org/10.3390/dermatopathology10010008
“Nitrogen Containing Heterocycles as Anticancer Agents: A Medicinal Chemistry Perspective”
by Adarsh Kumar, Ankit Kumar Singh, Harshwardhan Singh, Veena Vijayan, Deepak Kumar, Jashwanth Naik, Suresh Thareja, Jagat Pal Yadav, Prateek Pathak, Maria Grishina et al.
Pharmaceuticals 2023, 16(2), 299; https://doi.org/10.3390/ph16020299
“Artificial Intelligence in Brain Tumor Imaging: A Step toward Personalized Medicine”
by Maurizio Cè, Giovanni Irmici, Chiara Foschini, Giulia Maria Danesini, Lydia Viviana Falsitta, Maria Lina Serio, Andrea Fontana, Carlo Martinenghi, Giancarlo Oliva and Michaela Cellina
Curr. Oncol. 2023, 30(3), 2673–2701; https://doi.org/10.3390/curroncol30030203
“Triple Negative Breast Cancer Treatment Options and Limitations: Future Outlook”
by Onyinyechi Obidiro, Gantumur Battogtokh and Emmanuel O. Akala
Pharmaceutics 2023, 15(7), 1796; https://doi.org/10.3390/pharmaceutics15071796
“Biomarkers in Breast Cancer: An Old Story with a New End”
by Lyvia Neves Rebello Alves, Débora Dummer Meira, Luiza Poppe Merigueti, Matheus Correia Casotti, Diego do Prado Ventorim, Jucimara Ferreira Figueiredo Almeida, Valdemir Pereira de Sousa, Marllon Cindra Sant’Ana, Rahna Gonçalves Coutinho da Cruz, Luana Santos Louro et al.
Genes 2023, 14(7), 1364; https://doi.org/10.3390/genes14071364
“Could Microbiome Be the Common Co-Denominator between Type 2 Diabetes and Pancreatic Cancer?”
by Marin Golčić and Andrej Belančić
Diabetology 2023, 4(4), 553–559; https://doi.org/10.3390/diabetology4040049
“Targeting Solute Carrier Transporters (SLCs) as a Therapeutic Target in Different Cancers”
by Ravi Bharadwaj, Swati Jaiswal, Erandi E. Velarde de la Cruz and Ritesh P. Thakare
Diseases 2024, 12(3), 63; https://doi.org/10.3390/diseases12030063
“Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic Cancer”
by Dimitrios Stefanoudakis, Maximos Frountzas, Dimitrios Schizas, Nikolaos V. Michalopoulos, Alexandra Drakaki and Konstantinos G. Toutouzas
Curr. Issues Mol. Biol. 2024, 46(4), 2827–2844; https://doi.org/10.3390/cimb46040177
“Metformin: From Diabetes to Cancer—Unveiling Molecular Mechanisms and Therapeutic Strategies”
by Emilia Amengual-Cladera, Pere Miquel Morla-Barcelo, Andrea Morán-Costoya, Jorge Sastre-Serra, Daniel Gabriel Pons, Adamo Valle, Pilar Roca and Mercedes Nadal-Serrano
Biology 2024, 13(5), 302; https://doi.org/10.3390/biology13050302
“Immune Checkpoint Inhibitors: Fundamental Mechanisms, Current Status and Future Directions”
by Abdullah Younis and John Gribben
Immuno 2024, 4(3), 186–210; https://doi.org/10.3390/immuno4030013
“Breast Cancer Screening among African Immigrants in the United States: An Integrative Review of Barriers, Facilitators, and Interventions”
by Julian I. Rauch, Joseph Daniels, Alyssa Robillard and Rodney P. Joseph
Int. J. Environ. Res. Public Health 2024, 21(8), 1004; https://doi.org/10.3390/ijerph21081004
“Predicting Leukoplakia and Oral Squamous Cell Carcinoma Using Interpretable Machine Learning: A Retrospective Analysis”
by Salem Shamsul Alam, Saif Ahmed, Taseef Hasan Farook and James Dudley
Oral 2024, 4(3), 386–404; https://doi.org/10.3390/oral4030032
 |
 |
 |
 |
 |
30 January 2025
Journal of Clinical Medicine | 2024 Annual Recommended Articles (I)
26 January 2025
World Neglected Tropical Diseases Day—30 January 2025
On 31 May 2021, the World Health Assembly (WHA) recognized 30 January as World Neglected Tropical Disease (NTD) Day. This decision formalized 30 January as a day to create better awareness on the devastating impact of NTDs on the poorest populations around the world. The day is also an opportunity to call on everyone to support the growing momentum for the control, elimination and eradication of these diseases.
We would like to recommend some related articles, Special Issues, and journals in the field of medicine & pharmacology as suitable communication platforms for you. We believe that sharing research like this can help raise awareness of NTDs.
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
“A Fatal Case of Presumptive Diagnosis of Leptospirosis Involving the Central Nervous System”
by Christina Alexopoulou, Athanasia Proklou, Sofia Kokkini, Maria Raissaki, Ioannis Konstantinou and Eumorfia Kondili
Healthcare 2024, 12(5), 568; https://doi.org/10.3390/healthcare12050568
“Evaluation of an Artificial Intelligence-Based Tool and a Universal Low-Cost Robotized Microscope for the Automated Diagnosis of Malaria”
by Carles Rubio Maturana, Allisson Dantas de Oliveira, Francesc Zarzuela, Alejandro Mediavilla, Patricia Martínez-Vallejo, Aroa Silgado, Lidia Goterris, Marc Muixí, Alberto Abelló, Anna Veiga et al.
Int. J. Environ. Res. Public Health 2025, 22(1), 47; https://doi.org/10.3390/ijerph22010047
“Chagas Disease in the Non-Endemic Area of Rome, Italy: Ten Years of Experience and a Brief Overview”
by Maria Letizia Giancola, Andrea Angheben, Laura Scorzolini, Stefania Carrara, Ada Petrone, Antonella Vulcano, Raffaella Lionetti, Angela Corpolongo, Rosalia Marrone, Francesca Faraglia et al.
Infect. Dis. Rep. 2024, 16(4), 650-663; https://doi.org/10.3390/idr16040050
“Uptake and Effectiveness of Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine during Pregnancy in Africa: A Scoping Review”
by Gifty Osei Berchie, Patience Fakornam Doe, Theodora Dedo Azu, Joyce Agyeiwaa, Gifty Owusu, Christian Makafui Boso, Naomi Kyeremaa Yeboa, Dorcas Frempomaa Agyare, Irene Korkoi Aboh, Bernard Nabe et al.
Diseases 2024, 12(9), 203; https://doi.org/10.3390/diseases12090203
“Laparoscopic Management of Multiple Liver, Omental, Mesenteric, Peritoneal, and Round Ligament Hydatid Cysts—A Rare Report of a Case and a Systematic Literature Review”
by Alin Mihetiu, Dan Georgian Bratu, Ciprian Tanasescu, Bogdan Ioan Vintilă, Alexandra Sandu, Mariana Sandu, Dragos Serban, Dan Sabau and Adrian Hasegan
J. Pers. Med. 2024, 14(2), 205; https://doi.org/10.3390/jpm14020205
“False-Positive Malaria Rapid Diagnostic Test Likely Due to African Tick Bite Fever: A Case Report”
by Rahel T. Zewude, Syed Zain Ahmad, Tom Joseph and Andrea K. Boggild
Reports 2024, 7(4), 100; https://doi.org/10.3390/reports7040100
“Increasing Risk of Tick-Borne Disease through Growth Stages in Ticks”
by Makoto Kondo, Yoshiaki Matsushima, Takehisa Nakanishi, Shohei Iida, Habe Koji and Keiichi Yamanaka
Clin. Pract. 2023, 13(1), 246-250; https://doi.org/10.3390/clinpract13010022
“Oral Chagas Disease in Colombia—Confirmed and Suspected Routes of Transmission”
by Norman L. Beatty, Catalina Arango-Ferreira, Lídia Gual-Gonzalez, Sara Zuluaga, Melissa S. Nolan and Omar Cantillo-Barraza
Trop. Med. Infect. Dis. 2024, 9(1), 14; https://doi.org/10.3390/tropicalmed9010014
“Global Patterns of Trends in Incidence and Mortality of Dengue, 1990–2019: An Analysis Based on the Global Burden of Disease Study”
by Irena Ilic and Milena Ilic
Medicina 2024, 60(3), 425; https://doi.org/10.3390/medicina60030425
“DengueFog: A Fog Computing-Enabled Weighted Random Forest-Based Smart Health Monitoring System for Automatic Dengue Prediction”
by Ashima Kukkar, Yugal Kumar, Jasminder Kaur Sandhu, Manjit Kaur, Tarandeep Singh Walia and Mohammed Amoon
Diagnostics 2024, 14(6), 624; https://doi.org/10.3390/diagnostics14060624
“Global Fight against Malaria: Goals and Achievements 1900–2022”
by Marc Thellier, Ayawovi Arlene Jessicka Gemegah and Ilhame Tantaoui
J. Clin. Med. 2024, 13(19), 5680; https://doi.org/10.3390/jcm13195680
“Oropouche Virus Exposure in Febrile Patients during Chikungunya Virus Introduction in the State of Amapá, Amazon Region, Brazil”
by Raquel Curtinhas de Lima, Helver Gonçalves Dias, Thiara Manuele Alves de Souza, Débora Familiar-Macedo, Edcelha D’Athaide Ribeiro, Valmir Corrêa e Corrêa, Alex Pauvolid-Corrêa, Elzinandes Leal de Azeredo and Flávia Barreto dos Santos
Pathogens 2024, 13(6), 469; https://doi.org/10.3390/pathogens13060469
“Adenovirus-Mediated Expression of Dengue Virus 2 Envelope Ferritin Nanoparticles Induced Virus-Specific Immune Responses in BALB/c Mice”
by M.S.B.W.T.M. Nipuna Sudaraka Tennakoon, Ji-Hoon Ryu, Yong-Sam Jung, Yingjuan Qian and Hyun-Jin Shin
Microbiol. Res. 2024, 15(3), 1913-1923; https://doi.org/10.3390/microbiolres15030128
“Evolution of the Quinoline Scaffold for the Treatment of Leishmaniasis: A Structural Perspective”
by Carlos F. M.Silva, Diana C. G. A. Pinto, Pedro A. Fernandes and Artur M. S. Silva
Pharmaceuticals 2024, 17(3), 285; https://doi.org/10.3390/ph17030285
“Prevalence of Intestinal Parasites, Protozoans and Soil-Transmitted Helminths, in Children from Communities of Northern Argentina after the Interruption of Deworming”
by Ernesto Candela, Rubén O. Cimino, Leonardo Sandon, Carla Muñoz-Antoli and María Victoria Periago
Parasitologia 2024, 4(2), 172-183; https://doi.org/10.3390/parasitologia4020015
“Global Lipidomics Reveals the Lipid Composition Heterogeneity of Extracellular Vesicles from Drug-Resistant Leishmania”
by Sehyeon (Erica) Kim, Ana Victoria Ibarra-Meneses, Christopher Fernandez-Prada and Tao Huan
Metabolites 2024, 14(12), 658; https://doi.org/10.3390/metabo14120658
|
Special Issue: “Infectious Disease Prevention and Public Health Promotion: Second Edition” |
Special Issue: “Advances in Molecular Diagnosis in Neglected Tropical Diseases” |
|
|
|
|
Special Issue: “One Health and Neglected Zoonotic Diseases” |
Special Issue: “Dysbiosis and Metabolic Disorders of the Microbiota” |
|
|
|
26 January 2025
Meet Us at the 55th Annual Meeting of the Japanese Society for Cardiovascular Surgery, 20–22 February 2025, Yamaguchi, Japan
